MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,617K
Free Cash flow
-$2,649K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid and other current assets
Share-based compensation
Net proceeds from issuance of co...
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable, accrued liabil...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,929
-4,489
-2,954
-4,249
Share-based compensation
214
364
225
1,001
Depreciation and amortization
3
2
15
44
Loss from equity method investment
-
-
0
0
Impairment of non-financial asset
-
-
127
-
Amortization/accretion on marketable securities
0
0
0
14
Allowance for credit losses
-
-
500
-
Accounts receivable
0
0
-3
1
Prepaid and other current assets
-396
-807
-335
-344
Other assets
-21
0
0
-50
Accounts payable, accrued liabilities and other liabilities
-354
233
-1,500
252
Net cash used in operating activities
-2,649
-3,083
-3,249
-3,342
Purchase of marketable securities
0
0
0
0
Sale of marketable securities
0
0
0
5,150
Investment in impilo therapeutics
-
-
0
-
Purchase of property and equipment
0
0
0
0
Investment in impilo therapeutics
-
-
-
0
Net cash provided by investing activities
0
0
0
5,150
Proceeds from exercise of options
0
124
0
0
Tax withholding payments on net share settlement equity awards
0
159
0
0
Proceeds from exercise of warrants
0
216
-
-
Net proceeds from issuance of common stock
29
0
205
353
Net cash provided by financing activities
29
181
205
353
Effect of exchange rate changes on cash
3
6
2
2
Net (decrease) increase in cash and cash equivalents
-2,617
-2,896
-3,042
2,163
Cash and cash equivalents at beginning of period
13,060
15,956
18,998
16,209
Cash and cash equivalents at end of period
10,443
13,060
15,956
18,998
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
issuance of common stock
$29K
(-89.86%↓ Y/Y)
Net cash provided by
financing activities
$29K
(-29.27%↓ Y/Y)
Effect of exchange rate
changes on cash
$3K
(-57.14%↓ Y/Y)
Net (decrease)
increase in cash and cash...
-$2,617K
(-518.05%↓ Y/Y)
Canceled cashflow
$32K
Prepaid and other
current assets
-$396K
(-528.57%↓ Y/Y)
Share-based compensation
$214K
(-72.17%↓ Y/Y)
Other assets
-$21K
(76.67%↑ Y/Y)
Depreciation and
amortization
$3K
(-96.55%↓ Y/Y)
Net cash used in
operating activities
-$2,649K
(71.69%↑ Y/Y)
Canceled cashflow
$634K
Net loss
-$2,929K
(68.78%↑ Y/Y)
Accounts payable,
accrued liabilities and...
-$354K
(73.22%↑ Y/Y)
Buy us a coffee
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)